Harrisburg, NC -- (SBWIRE) -- 10/28/2020 -- Global Diabetic Eye Disease Devices Market recently Published Market Insights Reports with more than 100 industry informative desk and Figures spread through Pages and easy to understand detailed TOC on Diabetic Eye Disease Devices Market".
Diabetic Eye Disease Devices Market Size was valued at USD 8 billion in 2019 and is expected to witness 6.9% CAGR from 2020 to 2026
Global Diabetic Eye Disease Devices Market 2020: This Report provides highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on Markets and materials, capacities and on the changing structure of the Diabetic Eye Disease Devices. The report also presents forecasts for Global Diabetic Eye Disease Devices Market investments from 2020 till 2026.
Inquire here to avail discount on this report:
https://www.marketinsightsreports.com/reports/02191101095/global-diabetic-eye-disease-devices-market-insights-forecast-to-2025/inquiry?mode=54
Leading key Company's Covered for this Research are IRIDEX,Ellex, Alcon,Bausch & Lomb, Synergetics USA,Topcon, Carl Zeiss Meditec, Abbott Medical Optics, NIDEK,Quantel,Rhein Medical,Lumenis,Meridian.
Diabetic Eye Disease DevicesBreakdown Data by Type
Laser Surgery
Vitrectomy
Diabetic Eye Disease DevicesBreakdown Data by Application
Hospitals
Clinics
FEB 9, 2015 : Lucentis was one of the top-selling drugs for Roche in 2014, generating sales of CHF1.7 billion, up 2% year over year due to its increased adoption for treating DME. Label expansion of the drug will further boost its sales.
We remind investors that Lucentis was approved by the FDA for the treatment of DME in 2012. The drug is also approved for patients with wet age-related macular degeneration (wet AMD) and macular edema following retinal vein occlusion.
As per Roche, nearly 750,000 people in the U.S. suffer from DME, of which about 10% are DR patients.
Roche markets Lucentis in the U.S., while Novartis ( NVS ) has exclusive commercial rights for the rest of the world.
FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy (View More Related Report: https://www.marketinsightsreports.com/reports/0716693865/global-diabetic-retinopathy-market-size-status-and-forecast-2025?mode=54 )
MAY 13, 2019 :Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection to treat all stages of diabetic retinopathy (DR), and thereby reduce the risk of blindness.
The PANORAMA trial showed that by one year, 20% of untreated patients developed proliferative diabetic eye disease, and EYLEA reduced this risk by 85% to 88% when administered using an every 16-week or eight-week dosing regimen, respectively," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer at Regeneron. "In fact, 80% of patients who received the EYLEA eight-week dosing regimen had significant improvement in their diabetic retinopathy."
Ask For Discount https://www.marketinsightsreports.com/reports/02191101095/global-diabetic-eye-disease-devices-market-insights-forecast-to-2025/discount?mode=54
Scope Of The Report
The research report on the global Diabetic Eye Disease Devices Market is a comprehensive publication that aims to identify the financial outlook of the market. For the same reason, it offers a detailed understanding of the competitive landscape. It studies some of the leading players, their management styles, their research and development statuses, and their expansion strategies. The report also includes product portfolios and the list of products in the pipeline. It includes a thorough explanation of the cutting-edging technologies and investments being made to upgrade the existing ones.
Table of Content
1 Introduction of Global Diabetic Eye Disease Devices Market
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 Executive Summary
3 Research Methodology
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 Global Diabetic Eye Disease Devices Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Diabetic Eye Disease Devices Market, By Deployment Model
5.1 Overview
6 Global Diabetic Eye Disease Devices Market, By Solution
6.1 Overview
7 Global Diabetic Eye Disease Devices Market, By Vertical
7.1 Overview
8 Global Diabetic Eye Disease Devices Market, By Geography
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
8.5.1 Latin America
8.5.2 Middle East
9 Global Diabetic Eye Disease Devices Market Competitive Landscape
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 Company Profiles
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
11 Appendix
Influence of the Diabetic Eye Disease Devices market report:
-Comprehensive assessment of all opportunities and risk in the market.
– Diabetic Eye Disease Devices market recent innovations and major events.
-Detailed study of business strategies for growth of the market-leading players.
-Conclusive study about the growth plot of Diabetic Eye Disease Devices market for forthcoming years.
-In-depth understanding of market-particular drivers, constraints and major micro markets.
-Favorable impression inside vital technological and market latest trends striking the market.
Browse Full Report: https://www.marketinsightsreports.com/reports/02121090101/global-aluminum-plates-market-research-report-2019?mode=54
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
We Also Offer Customization on report based on specific client Requirement:
– Free country Level analysis for any 5 countries of your choice.
– Free Competitive analysis of any 5 key market players.
– Free 40 analyst hours to cover any other data point.